Belite Bio Ownership | Who Owns Belite Bio?
Belite Bio Ownership Summary
Belite Bio is owned by 0.26% institutional investors, 58.60% insiders, and 41.14% retail investors. State street is the largest institutional shareholder, holding 0.05% of BLTE shares. SPDR® Portfolio Emerging Markets ETF is the top mutual fund, with 0.03% of its assets in Belite Bio shares.
BLTE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Belite Bio | 0.26% | 58.60% | 41.14% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| State street | 15.67K | 0.05% | $715.85K |
| Point72 asset management | 7.31K | 0.02% | $333.97K |
| Geode capital management | 6.70K | 0.02% | $306.06K |
| Virtus etf advisers | 1.81K | 0.01% | $82.54K |
| Morgan stanley | 1.04K | 0.00% | $47.69K |
| Bank of america corp /de/ | 102.00 | 0.00% | $4.66K |
| Jpmorgan chase | 88.00 | 0.00% | $4.02K |
| Hrt financial lp | - | - | - |
| Armistice capital | - | - | - |
| Advisor group | 8.00 | - | $365.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Virtus etf advisers | 1.81K | 0.04% | $82.54K |
| Point72 asset management | 7.31K | 0.00% | $333.97K |
| Advisor group | 8.00 | - | $365.00 |
| Bank of america corp /de/ | 102.00 | - | $4.66K |
| State street | 15.67K | - | $715.85K |
| Jpmorgan chase | 88.00 | - | $4.02K |
| Hrt financial lp | - | - | - |
| Armistice capital | - | - | - |
| Cubist systematic strategies | - | - | - |
| Geode capital management | 6.70K | - | $306.06K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Advisor group | 8.00 | - | 3.00 |
| Geode capital management | 6.70K | - | - |
| Virtus etf advisers | 1.81K | 0.04% | -152.00 |
| Jpmorgan chase | 88.00 | - | -570.00 |
| State street | 15.67K | - | -999.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -148.00K |
| Marshall wace, llp | - | - | -10.58K |
| Hrt financial lp | - | - | -5.41K |
| Morgan stanley | 1.04K | - | -5.05K |
| Cubist systematic strategies | - | - | -4.79K |
Sold Out
| Holder | Change |
|---|---|
| Cubist systematic strategies | -4.79K |
| Hrt financial lp | -5.41K |
| Marshall wace, llp | -10.58K |
| Armistice capital | -148.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 15 | 36.36% | 78,699 | -57.82% | - | 64.88% | 11 | 175.00% | 2 | -66.67% |
| Jun 30, 2024 | 10 | -9.09% | 186,140 | 220.31% | - | 1489.38% | 3 | 50.00% | 6 | -25.00% |
| Mar 31, 2024 | 11 | -35.29% | 58,112 | -62.53% | - | 63.65% | 2 | -86.67% | 8 | 700.00% |
| Dec 31, 2023 | 17 | 142.86% | 155,109 | 55.74% | - | 380.68% | 15 | 200.00% | 1 | - |
| Sep 30, 2023 | 7 | 16.67% | 99,593 | -90.43% | - | 1.57% | 5 | 25.00% | 1 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| SPDR® Portfolio Emerging Markets ETF | 9.98K | 0.03% | - |
| SPDR® S&P Emerging Markets Small Cap ETF | 8.29K | 0.03% | -69.00 |
| Fidelity Nasdaq Composite Index | 6.70K | 0.02% | - |
| ActivePassive International Equity ETF | 2.39K | 0.01% | - |
| Virtus LifeSci Biotech Clinical Trls ETF | 1.84K | 0.01% | - |
| SPDR® S&P China ETF | 1.67K | 0.01% | - |
| CIBC US Broad Market Index | 750.00 | 0.00% | 41.00 |
| JHVIT Total Stock Market Index I | 486.00 | 0.00% | - |
| FT Wilshire 5000 Index Instl | 146.00 | 0.00% | - |
| QRG QP: Emerging Markets ADR Beta | 43.00 | 0.00% | -5.00 |
BLTE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools